Company Overview
ANAPTYSBIO, INC
ANABRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
258M
2025 FY
Net Income
-13M
2025 FY
Shares Outstanding
29M
2025 FY
EPS
-0.46USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1370053
Exchange
Nasdaq
Location
US